Inventor · disambiguated record
Wei Yao
Also filed as: MICHEJDA LEGAL REPRESENTATIVE MARIA · YAO WEI · YAO WEI-CHI
34 granted patents·16 pending applications·820 citations·filing 2004–2025
98Inventor score
Files withINTRA CELLULAR THERAPIES INC26UNIV CALIFORNIA7HENKEL AG & CO KGAA5UNIV DREXEL4TOMESCH JOHN CHARLES2
Top patents by PatentIndex Score
50 records- 0198US11844757B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Dec 19, 2023·10 cites·14 claims
- 0298US11806347B2Transmucosal methods for treating psychiatric and neurological conditionsINTRA CELLULAR THERAPIES INC·Filed 2021·Granted Nov 7, 2023·20 cites·58 claims
- 0398US11723909B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2021·Granted Aug 15, 2023·18 cites·34 claims
- 0498US11096944B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Aug 24, 2021·28 cites·28 claims
- 0598US11052083B2Transmucosal methods for treating psychiatric and neurological conditionsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jul 6, 2021·27 cites·26 claims
- 0698US10799500B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Oct 13, 2020·28 cites·17 claims
- 0798US10688097B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Jun 23, 2020·48 cites·23 claims
- 0898US10464938B2Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 5, 2019·33 cites·12 claims
- 0998US10245260B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Apr 2, 2019·38 cites·15 claims
- 1098US9751883B2Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2016·Granted Sep 5, 2017·86 cites·28 claims
- 1198US9315504B2Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereofINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Apr 19, 2016·88 cites·5 claims
- 1297US11376249B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jul 5, 2022·29 cites·19 claims
- 1397US11066407B2Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jul 20, 2021·14 cites·10 claims
- 1497US10716786B2Transmucosal and subcutaneous compositionsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jul 21, 2020·38 cites·24 claims
- 1597US10597395B2Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 24, 2020·23 cites·19 claims
- 1697US10221176B2Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Mar 5, 2019·28 cites·29 claims
- 1797US8779139B2Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereofTOMESCH JOHN CHARLES·Filed 2012·Granted Jul 15, 2014·108 cites·15 claims
- 1897US8309722B2Substituted heterocycle gamma-carbolines synthesisTOMESCH JOHN CHARLES·Filed 2008·Granted Nov 13, 2012·117 cites·44 claims
- 1996US12194044B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Jan 14, 2025·3 cites·31 claims
- 2094US9561256B2LLP2A-bisphosphonate conjugates for osteoporosis treatmentUNIV CALIFORNIA·Filed 2015·Granted Feb 7, 2017·9 cites·14 claims
- 2191US2025101022A1PROCESS FOR PREPARING INTERMEDIATES FOR 1-(4-FLUOROPHENYL)-4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3’,4’:4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)BUTAN-1-ONEINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 2290US2025136009A1Two-dimensional (2-d) arrays of transition metal nitrides for li-metal anodesUNIV DREXEL·Filed 2024·Application pending·0 cites
- 2388US12336989B2Transmucosal methods for treating psychiatric and neurological conditionsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Jun 24, 2025·0 cites·33 claims
- 2487US2025149737A1Mxene-polymer separators for li-ion batteriesUNIV DREXEL·Filed 2024·Application pending·0 cites
- 2586US12268686B2Transmucosal methods for treating psychiatric and neurological conditionsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Apr 8, 2025·0 cites·33 claims
- 2686US2025099471A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2024·Application pending·0 cites
- 2785US12440489B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2023·Granted Oct 14, 2025·0 cites·17 claims
- 2885US10494401B2LLP2A-bisphosphonate conjugates for osteoporosis treatmentUNIV CALIFORNIA·Filed 2016·Granted Dec 3, 2019·4 cites·19 claims
- 2985US7504430B2Maleiimide anti-tumor phosphatase inhibitorsUS HEALTH·Filed 2006·Granted Mar 17, 2009·7 cites·41 claims
- 3084US9119884B2LLP2A-bisphosphonate conjugates for osteoporosis treatmentLAM KIT S·Filed 2012·Granted Sep 1, 2015·7 cites·22 claims
- 3183US12139490B2Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-oneINTRA CELLULAR THERAPIES INC·Filed 2022·Granted Nov 12, 2024·0 cites·18 claims
- 3283US2025275962A1Transmucosal methods for treating psychiatric and neurological conditionsINTRA CELLULAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 3380US10287444B2EMI shielding composition and process for applying itHENKEL AG & CO KGAA·Filed 2016·Granted May 14, 2019·5 cites·12 claims
- 3478US9796898B2Single crystal alumina filled die attach pasteHENKEL AG & CO KGAA·Filed 2016·Granted Oct 24, 2017·2 cites·14 claims
- 3575US2020369723A1Llp2a-bisphosphonate conjugates for osteoporosis treatmentUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 3670US2021261612A1Llp2a-bisphosphonate conjugates for osteoporosis treatmentUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3769US2022296591A1Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 3869US2022231379A1Mxene-polymer separators for li-ion batteriesUNIV DREXEL·Filed 2020·Application pending·0 cites
- 3967US2024099311A1Virulence factor fspl gene from sugarcane pokkah boeng disease and use thereofUNIV GUANGXI·Filed 2023·Application pending·0 cites
- 4065US2022231293A1Two-dimensional (2-d) arrays of transition metal nitrides for li-metal anodesUNIV DREXEL·Filed 2020·Application pending·0 cites
- 4164US2024240067A1Thermally conductive adhesive composition, preparation method and use thereofHENKEL AG & CO KGAA·Filed 2024·Application pending·0 cites
- 4261US12157778B2Peptides for activation of cell signaling in osteoprogenitor cellsUNIV CALIFORNIA·Filed 2021·Granted Dec 3, 2024·0 cites·7 claims
- 4361US2016243250A1Treating inflammation using llp2a-bisphosphonate conjugates and mesenchymal stem cellsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 4460US12344739B2Conductive epoxy resin composition for copper bondingHENKEL AG & CO KGAA·Filed 2023·Granted Jul 1, 2025·0 cites·16 claims
- 4558US2019076448A1Methods of treating osteonecrosis with llp2a-bisphosphonate compoundsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 4655US12051522B2Silver sintering composition containing copper alloy for metal bondingHENKEL AG & CO KGAA·Filed 2022·Granted Jul 30, 2024·0 cites·19 claims
- 4749US2022088014A1Methods of treating addictionINTRA CELLULAR THERAPIES INC·Filed 2020·Application pending·0 cites
- 4843US7215522B2Power module of field emission display and method of power generation thereofTECO NANOTECH CO LTD·Filed 2004·Granted May 8, 2007·2 cites·10 claims
- 4932US2017018501A1Via structures for thermal dissipationAVAGO TECHNOLOGIES GENERAL IP·Filed 2015·Application pending·0 cites
- 5014US7718742B2Industrial syntheses process of high tran-1, 4-polyisopreneQINGDAO QUST FANGTAI MATERIAL·Filed 2007·Granted May 18, 2010·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Wei Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →